...
首页> 外文期刊>European review for medical and pharmacological sciences. >Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis
【24h】

Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis

机译:Circ-0104631促进结直肠癌中的细胞增殖和侵袭并预测不良预后

获取原文
           

摘要

OBJECTIVE: The aim of this study was to elucidate the effect of Circ-0104631 on the progression of colorectal cancer (CRC) and to demonstrate the underlying mechanism. Our research might provide new biological markers and molecular therapeutic targets for the diagnosis and therapy of CRC. PATIENTS AND METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was applied to detect Circ-0104631 expression in human colorectal cancer tissues and normal control tissues. To further explore the effect of Circ-0104631 on CRC in vitro, we first knocked down Circ-0104631 in colorectal cancer cells (SW480 and LoVo) by shRNA transfection. Subsequently, we detected its effect on cell proliferation and invasion by cell counting kit-8 (CCK-8) assay, colony formation assay and cell invasion assay, respectively. The regulation of Circ-0104631 on the expressions of phosphate and tension homology deleted on chromosome ten (PTEN)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway-related proteins was detected by Western blot. Besides, the regulatory mechanism of Circ-0104631 on the progression and metastasis of CRC was further verified by recovery experiments. RESULTS: QRT-PCR results showed that Circ-0104631 was highly expressed in tissues of patients with CRC when compared with that of normal control tissues. At the same time, we also found that the expression of Circ-010463 was significantly up-regulated in CRC tissues with high topography lymph node metastasis (TNM) stage and distant metastasis. Survival curve analysis indicated that high expression of Circ-010463 predicted poor prognosis of CRC patients. In vitro experiment demonstrated that inhibition of Circ-0104631 in SW480 and LoVo cells could markedly decrease cell growth and metastasis abilities. Meanwhile, Western blot results indicated that the protein expression of PTEN increased significantly, while p-Akt and p-mTOR decreased remarkably after knock-down of Circ-0104631 in CRC cells. Furthermore, recovery experiments illustrated that knockdown of PTEN in SW480 and LoVo cells partially attenuated the inhibitory effect of shRNA-Circ-0104631 on cell growth and metastasis. CONCLUSIONS: Circ-0104631 was highly expressed in CRC tissues. Furthermore, knockdown of Circ-0104631 could inhibit the growth and metastasis of CRC cells by regulating PTEN/Akt/mTOR signaling pathway.
机译:目的:本研究的目的是阐明Circ-0104631对结直肠癌(CRC)进展的影响并证明其潜在机制。我们的研究可能为CRC的诊断和治疗提供新的生物学标记和分子治疗靶标。病人和方法:实时定量聚合酶链反应(qRT-PCR)用于检测人大肠癌组织和正常对照组织中Circ-0104631的表达。为了进一步探讨Circ-0104631在体外对CRC的影响,我们首先通过shRNA转染敲除了Circ-0104631在大肠癌细胞(SW480和LoVo)中的作用。随后,我们分别通过细胞计数试剂盒8(CCK-8)测定,集落形成测定和细胞侵袭测定来检测其对细胞增殖和侵袭的影响。 Western blot检测Circ-0104631对十号染色体(PTEN)/蛋白激酶B(Akt)/哺乳动物雷帕霉素靶标(mTOR)信号通路相关蛋白缺失的磷酸化表达和张力同源性的调控。此外,通过恢复实验进一步验证了Circ-0104631对CRC进展和转移的调控机制。结果:QRT-PCR结果显示,与正常对照组织相比,Circ-0104631在CRC患者组织中高表达。同时,我们还发现在具有高形貌淋巴结转移(TNM)阶段和远处转移的CRC组织中,Circ-010463的表达明显上调。生存曲线分析表明,Circ-010463的高表达预示了CRC患者的不良预后。体外实验表明,在SW480和LoVo细胞中抑制Circ-0104631可以显着降低细胞生长和转移能力。同时,Western blot结果表明,敲除Circ-0104631后,CRC细胞中PTEN的蛋白表达显着增加,而p-Akt和p-mTOR显着下降。此外,恢复实验表明,SW480和LoVo细胞中PTEN的敲低部分减弱了shRNA-Circ-0104631对细胞生长和转移的抑制作用。结论:Circ-0104631在CRC组织中高表达。此外,敲除Circ-0104631可以通过调节PTEN / Akt / mTOR信号通路抑制CRC细胞的生长和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号